HomeWistar TodayWistar WireMelanomaWistar Wire: Melanoma
Wistar Today

Wistar Wire: Melanoma

Tags

Expert Opinion: Melanoma Risk Still High in the Winter.
January 23, 2013
wistar
It may not seem like it, but the winter sun still packs a punch, especially when it comes to melanoma, an aggressive form of skin cancer. “There’s a saying we like to use: ‘Melanoma doesn’t hibernate.’ So just because it’s cold outside does not mean sun exposure can’t be dangerous,” said Ashani Weeraratna, Ph.D.
Read Full Post
Cancer, Melanoma
The Paradox of BRAF Inhibitors in Melanoma Care
January 19, 2012
wistar
A BRAF inhibitor known as vemurafenib (Zelboraf) has been touted as a breakthrough melanoma treatment. But for some patients, the price of success is a mutation that leads to the development of secondary skin cancers called squamous cell carcinomas. In an editorial in The New England Journal of Medicine, Wistar researcher Ashani Weeraratna, Ph.D., discusses the success of a new combination treatment.
Read Full Post
Cancer, Genes, Melanoma
Team Approach Guides Wistar’s New Melanoma Research Center
June 30, 2010
wistar
On the heels of announcing findings that could change the way melanoma is treated, Wistar announced a new effort that will change the way scientists conduct melanoma research...
Read Full Post
Cancer, Melanoma
Skin Cancer on Trial
February 28, 2010
wistar
In modern medicine, many molecules are found to hold promise as potential new drugs, but, for many reasons, few ever make it to the clinic.
Read Full Post
Cancer, Melanoma